At the early stages of development of Parkinson’s disease, the use of Induced Pluripotent Stem Cells (iPSCs) instills hope for reducing the effects of this disease and augurs well for the possibilities of finding an effective treatment in the future. All the scientists involved in the Parkinsons stem cell treatments, however, agree that there is need for further and intensive research on this issue.
Finding a fully successful stem cell treatment for Parkinson’s disease is still long a way off. This not withstanding, there are high hopes of the acquisition of undifferentiated stem cells from the body of the patient and then stimulating nerve cell differentiation.
Induced Pluripotent Stem Cells (iPSCs) refer to special cells which have the unique characteristic and ability of developing into various types of cells in the body. In adults, there are also stem cells which are already partially differentiated and in theory are capable of replenishing body cells which have been worn out. Most of these cells are found in the hemopoietic tissue (in which blood cells are produced).
There are three types of stem cells namely the embryonic, non-embryonic and the Induced Pluripotent Stem Cells.
The EMRYONIC STEM CELLS is the source of all cell types. These cells can divide and replicate for long duration without differentiation to other types of cells. The source of these cells is the human embryo from where they are then taken to a laboratory to be expanded grown.
The NON - EMRYONIC STEM CELLS are those stem cells which are totally undifferentiated or partially differentiated and which are present amongst the differentiated cells in body organ or tissue. These stem cells usually undergo differentiation to produce cells which are similar to those which neighbor them. These stem cells are mostly involved in tissue repair.
The INDUCED PLURIPOTENT STEM CELLS (iPSCs) are the cells which form the bulk of stem cell treatment for Parkinson’s diseases. Specialized adult iPCs can be programmed genetically by the introducing embryonic genes so as to cause them to behave like the embryonic stem cells. The iPCs have a very great potential of undergoing differentiation or generating tissues and cells which are specified. The iPCs Parkinson disease stem cell treatment aims at replacing the dopaminergic neurons (which produce dopamine). The destruction of these cells is considered to be the underlying cause of Parkinson’s disease.